These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36372411)

  • 1. Diagnosis and Evaluation of Cardiac Amyloidosis with Noninvasive Multimodality Imaging.
    Wang J; Wang Y; Ren S; Chen Y; Chu H; Pang Z; Li J
    Int Heart J; 2022 Nov; 63(6):1194-1200. PubMed ID: 36372411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How to Image Cardiac Amyloidosis: A Practical Approach.
    Dorbala S; Cuddy S; Falk RH
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1368-1383. PubMed ID: 31607664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis.
    Baggiano A; Boldrini M; Martinez-Naharro A; Kotecha T; Petrie A; Rezk T; Gritti M; Quarta C; Knight DS; Wechalekar AD; Lachmann HJ; Perlini S; Pontone G; Moon JC; Kellman P; Gillmore JD; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):69-80. PubMed ID: 31202744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodality imaging approach to cardiac amyloidosis: part 2.
    Sennott J; Ananthasubramaniam K
    Heart Fail Rev; 2022 Sep; 27(5):1515-1530. PubMed ID: 34694574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
    Poterucha TJ; Elias P; Bokhari S; Einstein AJ; DeLuca A; Kinkhabwala M; Johnson LL; Flaherty KR; Saith SE; Griffin JM; Perotte A; Maurer MS
    JACC Cardiovasc Imaging; 2021 Jun; 14(6):1221-1231. PubMed ID: 33221204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Amyloidosis: The Exemplar Interstitial Disease.
    Fontana M; Ćorović A; Scully P; Moon JC
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2345-2356. PubMed ID: 31422120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis.
    Palot Manzil FF; Pandey T
    Cureus; 2023 Apr; 15(4):e37838. PubMed ID: 37214019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. It Takes a Village: Multimodality Imaging of Cardiac Amyloidosis.
    Saad JM; Ahmed AI; Anugula D; Han Y; Alfawara MS; Al-Mallah MH
    Methodist Debakey Cardiovasc J; 2022; 18(2):47-58. PubMed ID: 35414854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion Tensor Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
    Khalique Z; Ferreira PF; Scott AD; Nielles-Vallespin S; Martinez-Naharro A; Fontana M; Hawkins P; Firmin DN; Pennell DJ
    Circ Cardiovasc Imaging; 2020 May; 13(5):e009901. PubMed ID: 32408830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
    Knight DS; Zumbo G; Barcella W; Steeden JA; Muthurangu V; Martinez-Naharro A; Treibel TA; Abdel-Gadir A; Bulluck H; Kotecha T; Francis R; Rezk T; Quarta CC; Whelan CJ; Lachmann HJ; Wechalekar AD; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    JACC Cardiovasc Imaging; 2019 May; 12(5):823-833. PubMed ID: 29680336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
    de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
    Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Kumamoto criteria for prediction of
    Ochi Y; Kubo T; Baba Y; Ueda M; Miyagawa K; Noguchi T; Hirota T; Yamasaki N; Kitaoka H
    J Cardiol; 2021 Feb; 77(2):124-130. PubMed ID: 33132078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Noninvasive diagnosis of cardiac involvement by technetium-99m-pyrophosphate (Tc-99m PYP) myocardial scintigraphy in 2 cases of familial amyloid polyneuropathy and 1 case of secondary amyloidosis].
    Takezaki M; Ishida Y; Morozumi T; Tani A; Sato H; Hori M; Kitabatake A; Kamada T; Kimura K; Kozuka T
    Kaku Igaku; 1989 Dec; 26(12):1537-43. PubMed ID: 2560088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
    Zeng Y; Poterucha TJ; Einstein AJ; Zhang Q; Chen Y; Xie H; Wan K; Liang Y; Chen J; Tang G
    Medicine (Baltimore); 2021 Apr; 100(17):e25582. PubMed ID: 33907108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multimodality Imaging in the Diagnosis and Assessment of Cardiac Amyloidosis.
    Velaga J; Liew C; Choo Poh AC; Lee PT; Lath N; Low SC; Bharadwaj P
    World J Nucl Med; 2022 Sep; 21(3):173-183. PubMed ID: 36060088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis.
    Wu Z; Yu C
    BMC Cardiovasc Disord; 2021 Oct; 21(1):482. PubMed ID: 34620092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of the novel CMR parameter "myocardial transit-time" (MyoTT) for the assessment of microvascular changes in cardiac amyloidosis and hypertrophic cardiomyopathy.
    Chatzantonis G; Bietenbeck M; Florian A; Meier C; Stalling P; Korthals D; Reinecke H; Yilmaz A
    Clin Res Cardiol; 2021 Jan; 110(1):136-145. PubMed ID: 32372287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?
    Cuddy SAM; Bravo PE; Falk RH; El-Sady S; Kijewski MF; Park MA; Ruberg FL; Sanchorawala V; Landau H; Yee AJ; Bianchi G; Di Carli MF; Cheng SC; Jerosch-Herold M; Kwong RY; Liao R; Dorbala S
    JACC Cardiovasc Imaging; 2020 Jun; 13(6):1325-1336. PubMed ID: 32417333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.